Phospholipase A2 Receptor Antibodies (PLA2R)
UKAS schedule of accreditation
Primary (idiopathic) membranous nephropathy
MATERIAL PROVIDED: Liquid format. Normal and pathological human serum
DISTRIBUTIONS PER YEAR: 6
SAMPLES PER DISTRIBUTION: 2
FREQUENCY OF DISTRIBUTION: Every 2 months
PROGRAMME OF ANALYSIS:
Data entry is via the web for the submission of results. Data analysis is commenced 21 days after sample despatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics.
Qualitative responses are assessed by MI scoring in relation to the designated response
Laboratory performance is classified in terms of OMIS over a running analytical window of 6 distributions (12 months)
PERSISTENT POOR PERFORMANCE:
Defined as being in the poor performance category for two or more successive distributions
Immunology, Immunochemistry & Allergy (IIA)
The External Quality Assessment Scheme for Immunology, Immunochemistry & Allergy (IIA) was founded in 1982 by Dr Anthony Milford Ward at Northern General Hospital, Sheffield. In 1982 the Service became known as the UK National External Quality Assessment Service for Immunology, Immunochemistry & Allergy. UK NEQAS IIA is part of the Sheffield Teaching Hospitals NHS Foundation Trust.